What is Survodutide?
The short answer
Survodutide is a new lab-made peptide that copies two hormones, now in large trials.
What it is
Activates glucagon and GLP-1 receptors.
What people look into
Weight
- 4 sources
- Status as of
- How we source
- Ellum doesn't sell peptides.
Get updates on Survodutide
What it is
- Type
- Glucagon/GLP-1 dual agonist (peptide)
- Also known as
- bi 456906
- How it works
- Activates glucagon and GLP-1 receptors.
Regulatory status
Investigational (phase 3) How we label status
As of October 4, 2026, Survodutide is not FDA-approved for any use and is not on FDA's 503A bulks list. It is in phase 3 trials.
- Federal (FDA)
- Investigational, phase 3, no US submission found
- 503A compounding
- No category; not on 216.23 as of 2026-10-07; not an approved-drug component (as of October 7, 2026)
US enforcement actions
2 US enforcement actions since 2024.
Actions by US federal and state agencies whose documents name Survodutide. Each row links to the government's own document.
Scroll sideways to see all columns.
US enforcement actions table
| Date | Agency | Action | Document |
|---|---|---|---|
| FDA | Warning letter | FDA document, warning letter, August 24, 2026, on fda.gov | |
| FDA | Warning letter | FDA document, warning letter, December 10, 2024, on fda.gov |
References
Sources as of October 4, 2026